Dexamethasone in Prolonging the Duration of Spinal Anesthesia Among Pregnant Patients
NCT ID: NCT07088146
Last Updated: 2025-07-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
PHASE4
110 participants
INTERVENTIONAL
2025-07-20
2025-10-20
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Dexamethasone Intravenous Versus Intrathecal in Spinal Anesthesia
NCT05470530
Dexamethasone for Post-operative Pain After Cesarean Delivery Under Neuraxial Anesthesia.
NCT07257406
Bupivacaine Alone vs Bupivacaine and Dexmed in Cesarean Deliveries
NCT05469529
Intravenous Dexmedetomidine in Cesarean Section Under Spinal Anesthesia
NCT04358367
Effect of Intravenous Dexamethasone Before Spinal Anesthesia on Post-cesarean Section Pain
NCT03122756
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
OTHER
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group Dexamethasone
Dexamethasone
Immediately after sub-arachnoid block 8mg of Dexamethasone will be administered intravenously
Group Control
Placebo
2ml of Normal saline will be given intravenously immediately after administration of spinal anesthesia
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Dexamethasone
Immediately after sub-arachnoid block 8mg of Dexamethasone will be administered intravenously
Placebo
2ml of Normal saline will be given intravenously immediately after administration of spinal anesthesia
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Elective Cesarean section under Spinal Anesthesia.
Exclusion Criteria
* Body mass index \>35 kg/m2
* Diabetes mellitus
* Adrenal insufficiency
* Chronically receiving steroids
* Allergic to study medications
* Sensory block level less than T4
16 Years
40 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Rawalpindi Medical College
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Huda Tariq
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Abeera Zareen, MBBS,FCPS
Role: STUDY_CHAIR
Rawalpindi Medical College
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Benazir Bhutto Hospital Rawalpindi
Rawalpindi, Punjab Province, Pakistan
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
References
Explore related publications, articles, or registry entries linked to this study.
Abdel-Wahab AH, Abd Alla ES, Abd El-Azeem T. Effect of intravenous dexamethasone on the duration of hyperbaric bupivacaine spinal anesthesia in lower abdominal surgery, Randomized controlled trial. BMC Anesthesiol. 2023 Sep 22;23(1):323. doi: 10.1186/s12871-023-02282-y.
Related Links
Access external resources that provide additional context or updates about the study.
Related Info
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
201/IREF/RMU/2025
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.